Institution · Acceleron Pharma (United States)
Most cited papers from Acceleron Pharma (United States)
What are the most cited papers from Acceleron Pharma (United States)?
The most cited paper from Acceleron Pharma (United States) is "Ballistocardiography and Seismocardiography: A Review of Recent Advances" (Omer T. Inan, Pierre‐François Migeotte, Kwangsuk Park et al., 2014), with 772 citations. Next come "DNA-encoded chemistry: enabling the deeper sampling of chemical space" (631) and "Sotatercept for the Treatment of Pulmonary Arterial Hypertension" (616).
Showing 50 of 60 papers. Every paper with more than 104 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | Ballistocardiography and Seismocardiography: A Review of Recent Advances Omer T. Inan, Pierre‐François Migeotte, Kwangsuk Park et al. · IEEE Journal of Biomedical and Health Informatics | 7 Oct 2014 | 772 |
| 2 | DNA-encoded chemistry: enabling the deeper sampling of chemical space Robert A. Goodnow, Christoph E. Dumelin, Anthony D. Keefe · Nature Reviews Drug Discovery | 9 Dec 2016 | 631 |
| 3 | Sotatercept for the Treatment of Pulmonary Arterial Hypertension Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs et al. · New England Journal of Medicine | 31 Mar 2021 | 616 |
| 4 | Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes Pierre Fenaux et al. · New England Journal of Medicine | 8 Jan 2020 | 554 |
| 5 | Leptin targets in the mouse brain Michael M. Scott, Jennifer L. Lachey, Scott M. Sternson et al. · The Journal of Comparative Neurology | 23 Feb 2009 | 490 |
| 6 | Transforming growth factor-β superfamily ligand trap ACE-536 corrects anemia by promoting late-stage erythropoiesis Rajasekhar N.V.S. Suragani, Samuel M. Cadena, Sharon M Cawley et al. · Nature Medicine | 23 Mar 2014 | 445 |
| 7 | Leptin’s effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons José Donato, Roberta M. Cravo, Renata Frazão et al. · Journal of Clinical Investigation | 23 Dec 2010 | 360 |
| 8 | Incidence and distribution of argininosuccinate synthetase deficiency in human cancers Brian J. Dillon, Victor Gerardo Prieto, Steven A. Curley et al. · Cancer | 3 Feb 2004 | 342 |
| 9 | A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia Maria Domenica Cappellini et al. · New England Journal of Medicine | 25 Mar 2020 | 329 |
| 10 | Cardiovascular regulatory actions of the hypocretins in brain Willis K. Samson, Blake A. Gosnell, Jaw-Kang Chang et al. · Brain Research | Jun 1999 | 300 |
| 11 | Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study Uwe Platzbecker, Ulrich Germing, Katharina S. S. Götze et al. · The Lancet Oncology | 2 Sep 2017 | 290 |
| 12 | The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin M.S. Kim, C. J. Small, Sarah A. Stanley et al. · Journal of Clinical Investigation | Apr 2000 | 260 |
| 13 | ACTRIIA-Fc rebalances activin/GDF versus BMP signaling in pulmonary hypertension Lai‐Ming Yung, Peiran B Yang, Sachindra Raj Joshi et al. · Science Translational Medicine | 13 May 2020 | 243 |
| 14 | Myostatin inhibitor ACE‐031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo‐controlled clinical trial Craig Campbell, Hugh J. McMillan, Jean Kit-Wah Mah et al. · Muscle & Nerve | 27 Jul 2016 | 241 |
| 15 | Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease Sonia Vallet et al. · Proceedings of the National Academy of Sciences | Mar 2010 | 236 |
| 16 | Irisin-immunoreactivity in neural and non-neural cells of the rodent S.L. Dun, Rong‐Ming Lyu, Yu‐Hsin Chen et al. · Neuroscience | 5 Mar 2013 | 234 |
| 17 | Characterization of the Neuroanatomical Distribution of Agouti-Related Protein Immunoreactivity in the Rhesus Monkey and the Rat* Carrie Haskell‐Luevano, Peilin Chen, Chien Li et al. · Endocrinology | Mar 1999 | 230 |
| 18 | Soluble Endoglin Specifically Binds Bone Morphogenetic Proteins 9 and 10 via Its Orphan Domain, Inhibits Blood Vessel Formation, and Suppresses Tumor Growth Roselyne Castonguay, Eric D. Werner, Robert G. Matthews et al. · Journal of Biological Chemistry | 8 Jul 2011 | 222 |
| 19 | Inhibition of Bone Morphogenetic Protein Signaling Reduces Vascular Calcification and Atherosclerosis Matthias Derwall, Rajeev Kumar Malhotra, Carol S. C. Lai et al. · Arteriosclerosis Thrombosis and Vascular Biology | 6 Jan 2012 | 219 |
| 20 | Pressor effects of orexins injected intracisternally and to rostral ventrolateral medulla of anesthetized rats Chiung-Tong Chen, Ling-Ling Hwang, Jaw-Kang Chang et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology | Mar 2000 | 211 |
| 21 | Single-Dose, Randomized, Double-Blind, Placebo-Controlled Study of ACE-011 (ActRIIA-IgG1) in Postmenopausal Women Jon Ruckle, Mark Jacobs, William G. Kramer et al. · Journal of Bone and Mineral Research | 2 Dec 2008 | 210 |
| 22 | A Novel Reproductive Peptide, Phoenixin Gina L. C. Yosten, Rong‐Ming Lyu, Aaron J.W. Hsueh et al. · Journal of Neuroendocrinology | 11 Sep 2012 | 198 |
| 23 | Orexin A-like immunoreactivity in the rat brain C.-T. Chen, S.L. Dun, Ernest H. Kwok et al. · Neuroscience Letters | Feb 1999 | 185 |
| 24 | Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis Sara Isabel Cunha, Evangelia Pardali, Midory Thorikay et al. · The Journal of Experimental Medicine | 11 Jan 2010 | 176 |
| 25 | A single ascending‐dose study of muscle regulator ace‐031 in healthy volunteers Kenneth M. Attie, Niels Geert Borgstein, Yijun Yang et al. · Muscle & Nerve | 2 Aug 2012 | 176 |
| 26 | Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex Sharon A. Townson, Erik Martı́nez-Hackert, Chloé Greppi et al. · Journal of Biological Chemistry | 21 Jun 2012 | 176 |
| 27 | Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology Merry Jennifer Markham et al. · Journal of Clinical Oncology | 4 Feb 2020 | 175 |
| 28 | Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation Andrea Ulrike Steinbicker, Chetana Sachidanandan, Ashley J. Vonner et al. · Blood | 11 Mar 2011 | 174 |
| 29 | Central action of FGF19 reduces hypothalamic AGRP/NPY neuron activity and improves glucose metabolism Geneviève Marcelin, Young‐Hwan Jo, Xiaosong Li et al. · Molecular Metabolism | 23 Oct 2013 | 174 |
| 30 | Poly(ethylene glycol) (PEG) conjugated arginine deiminase: effects of PEG formulations on its pharmacological properties Frederick W. Holtsberg, Mark Ensor, Marion R. Steiner et al. · Journal of Controlled Release | Apr 2002 | 161 |
| 31 | ALK1-Fc Inhibits Multiple Mediators of Angiogenesis and Suppresses Tumor Growth Dianne Mitchell, Eileen G. Pobre, Aaron W. Mulivor et al. · Molecular Cancer Therapeutics | Feb 2010 | 154 |
| 32 | Characterization of the Ligand Binding Functionality of the Extracellular Domain of Activin Receptor Type IIB Dianne Sako, Asya V. Grinberg, June Liu et al. · Journal of Biological Chemistry | 13 Apr 2010 | 152 |
| 33 | Seismocardiography: Past, present and future John M. Zanetti, Kouhyar Tavakolian | Jul 2013 | 151 |
| 34 | Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension Marc Humbert, Vallerie V. McLaughlin, J. Simon R. Gibbs et al. · European Respiratory Journal | 30 Aug 2022 | 149 |
| 35 | Inhibiting activin-A signaling stimulates bone formation and prevents cancer-induced bone destruction in vivo Andrew Chantry, Debby Heath, Aaron W. Mulivor et al. · Journal of Bone and Mineral Research | 7 Jun 2010 | 148 |
| 36 | Modified activin receptor IIB ligand trap mitigates ineffective erythropoiesis and disease complications in murine β-thalassemia Rajasekhar N.V.S. Suragani, Sharon M Cawley, Robert Li et al. · Blood | 3 May 2014 | 147 |
| 37 | KiSS‐1 expression and metastin‐like immunoreactivity in the rat brain Gabriela Cristina Brailoiu, Siok L. Dun, Masahiro Ohsawa et al. · The Journal of Comparative Neurology | 9 Dec 2004 | 146 |
| 38 | Endomorphin-1 mediates 2 Hz but not 100 Hz electroacupuncture analgesia in the rat Han Zhou, Yuhui Jiang, You Wan et al. · Neuroscience Letters | Oct 1999 | 146 |
| 39 | A Selective Transforming Growth Factor-β Ligand Trap Attenuates Pulmonary Hypertension Lai‐Ming Yung, Ivana Nikolić, Samuel D Paskin-Flerlage et al. · American Journal of Respiratory and Critical Care Medicine | 26 Apr 2016 | 144 |
| 40 | Therapeutic effects of ghrelin on endotoxic shock in rats Lin Faun Chang, Jing Zhao, Jun Yang et al. · European Journal of Pharmacology | Jul 2003 | 142 |
| 41 | The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity Imo J. Akpan, Marcus DaSilva Goncalves, Rajiv Dhir et al. · International Journal of Obesity | 11 Aug 2009 | 140 |
| 42 | Coordinated Vascular Endothelial Growth Factor Expression and Signaling During Skeletal Myogenic Differentiation Brad Allen Bryan, Tony E. Walshe, Dianne Mitchell et al. · Molecular Biology of the Cell | 19 Dec 2007 | 137 |
| 43 | Series of Novel and Highly Potent Cyclic Peptide PCSK9 Inhibitors Derived from an mRNA Display Screen and Optimized via Structure-Based Design Candice Alleyne et al. · Journal of Medicinal Chemistry | 10 Nov 2020 | 136 |
| 44 | Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type Samuel M. Cadena, Kathleen N. Tomkinson, Travis E. Monnell et al. · Journal of Applied Physiology | 14 May 2010 | 136 |
| 45 | Sotatercept in patients with osteolytic lesions of multiple myeloma Kudrat Mugutdinovich Abdulkadyrov, Galina Salogub, Nuriet K. Khuazheva et al. · British Journal of Haematology | 21 Mar 2014 | 128 |
| 46 | A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys Sutada Lotinun, Robert Scott Pearsall, Monique V. Davies et al. · Bone | 19 Jan 2010 | 127 |
| 47 | Quantitation of protein particles in parenteral solutions using micro-flow imaging Chi-Ting Huang, Deepak Kumar Sharma, Peter Oma et al. · Journal of Pharmaceutical Sciences | 20 Oct 2008 | 127 |
| 48 | Urocortin 3 regulates glucose-stimulated insulin secretion and energy homeostasis Chien Li, Peilin Chen, Joan M. Vaughan et al. · Proceedings of the National Academy of Sciences | 27 Feb 2007 | 120 |
| 49 | Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla C.-T. Chen, S.L. Dun, Nae J. Dun et al. · Brain Research | Mar 1999 | 120 |
| 50 | Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial Rami S. Komrokji et al. · The Lancet Haematology | 10 Jan 2018 | 119 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.